Jushi Holdings (JUSHF) Total Liabilities (2021 - 2026)
Jushi Holdings' (JUSHF) quarterly Total Liabilities came in at $569.9 million in Q1 2026, up 14.1% year-on-year from $499.5 million in Q1 2025, and up 6.0% on a QoQ basis from $537.7 million in Q4 2025.
Jushi Holdings (JUSHF) Total Liabilities (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Total Liabilities data on file, last reported at $569.9 million in Q1 2026.
- On a quarterly basis, Total Liabilities rose 14.1% year-over-year to $569.9 million in Q1 2026; TTM through Mar 2026 was $569.9 million, a 14.1% increase from a year earlier, with the FY2025 full-year figure at $537.7 million, up 9.61% from the prior year.
- Total Liabilities for Q1 2026 stood at $569.9 million, up from $537.7 million in the prior quarter.
- Over the last five years, Total Liabilities for JUSHF reached as high as $569.9 million in Q1 2026 and fell as low as $466.4 million in Q1 2022.
- Historically, Total Liabilities has averaged $495.1 million across 5 years, with a median of $484.3 million in 2023.
- Across the five-year window, Total Liabilities declined 2.6% in 2023 and grew 14.1% in 2026, its largest moves.
- Year by year, Total Liabilities stood at $483.4 million in 2022, then fell by 2.57% to $471.0 million in 2023, then advanced by 4.15% to $490.6 million in 2024, then advanced by 9.61% to $537.7 million in 2025, then gained by 6.0% to $569.9 million in 2026.
- Per Business Quant data, the three most recent Total Liabilities figures were $569.9 million in Q1 2026, $537.7 million in Q4 2025, and $533.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 21.48 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 31.81 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.92 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 51.53 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 813.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 22.18 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.50 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.72 Bn |
| 10 | Jushi Holdings | 81.25 Mn | 41.54 Mn | 29.88 Mn | 569.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 569.93 Mn |
| Dec 31, 2025 | 537.69 Mn |
| Sep 30, 2025 | 533.17 Mn |
| Jun 30, 2025 | 510.21 Mn |
| Mar 31, 2025 | 499.50 Mn |
| Dec 31, 2024 | 490.56 Mn |
| Sep 30, 2024 | 481.01 Mn |
| Jun 30, 2024 | 479.02 Mn |
| Mar 31, 2024 | 481.43 Mn |
| Dec 31, 2023 | 471.01 Mn |
| Sep 30, 2023 | 480.84 Mn |
| Jun 30, 2023 | 474.01 Mn |
| Mar 31, 2023 | 484.27 Mn |
| Dec 31, 2022 | 483.45 Mn |
| Sep 30, 2022 | 487.95 Mn |
| Jun 30, 2022 | 486.67 Mn |
| Mar 31, 2022 | 466.40 Mn |
| Dec 31, 2021 | 471.07 Mn |